Human IL26 ELISA Kit (V2LY-0626-LY257)

Fries, A., Saidoune, F., Kuonen, F., Dupanloup, I., Fournier, N., Guerra de Souza, A. C., ... & Gilliet, M. (2023). Differentiation of IL-26+ TH17 intermediates into IL-17A producers via epithelial crosstalk in psoriasis. Nature Communications, 14(1), 3878.

Cardenas, E. I., Ekstedt, S., Piersiala, K., Petro, M., Karlsson, A., Kågedal, Å., ... & Lindén, A. (2022). Increased IL-26 associates with markers of hyperinflammation and tissue damage in patients with acute COVID-19. Frontiers in immunology, 13.

Cardenas, E. I., Che, K. F., Konradsen, J. R., Bao, A., & Lindén, A. (2022). IL-26 in asthma and COPD. Expert Review of Respiratory Medicine, 16(3), 293-301.

Beaumont, É., Larochette, V., Preisser, L., Miot, C., Pignon, P., Blanchard, S., ... & Delneste, Y. (2022). IL-26 inhibits hepatitis C virus replication in hepatocytes. Journal of Hepatology, 76(4), 822-831.

Gowhari Shabgah, A., Abdelbasset, W. K., Sulaiman Rahman, H., Bokov, D. O., Suksatan, W., Thangavelu, L., ... & Gholizadeh Navashenaq, J. (2022). A comprehensive review of IL‐26 to pave a new way for a profound understanding of the pathobiology of cancer, inflammatory diseases and infections. Immunology, 165(1), 44-60.

Itoh, T., Hatano, R., Horimoto, Y., Yamada, T., Song, D., Otsuka, H., ... & Ohnuma, K. (2021). IL-26 mediates epidermal growth factor receptor-tyrosine kinase inhibitor resistance through endoplasmic reticulum stress signaling pathway in triple-negative breast cancer cells. Cell Death & Disease, 12(6), 520.

Itoh, T., Hatano, R., Komiya, E., Otsuka, H., Narita, Y., Aune, T. M., ... & Ohnuma, K. (2019). Biological effects of IL-26 on T cell–mediated skin inflammation, including psoriasis. Journal of Investigative Dermatology, 139(4), 878-889.

Larochette, V., Miot, C., Poli, C., Beaumont, E., Roingeard, P., Fickenscher, H., ... & Delneste, Y. (2019). IL-26, a cytokine with roles in extracellular DNA-induced inflammation and microbial defense. Frontiers in immunology, 10, 204.

Dang, A. T., Teles, R. M., Weiss, D. I., Parvatiyar, K., Sarno, E. N., Ochoa, M. T., ... & Modlin, R. L. (2019). IL-26 contributes to host defense against intracellular bacteria. The Journal of clinical investigation, 129(5), 1926-1939.

Hatano, R., Itoh, T., Otsuka, H., Okamoto, S., Komiya, E., Iwata, S., ... & Morimoto, C. (2019, November). Characterization of novel anti-IL-26 neutralizing monoclonal antibodies for the treatment of inflammatory diseases including psoriasis. In mabs (Vol. 11, No. 8, pp. 1428-1442). Taylor & Francis.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols